August 26, 2020
Detection of Ebola virus illness epizootics.
Prolonged-term wildlife mortality surveillance in northern Congo: a model for the detection of Ebola virus sickness epizootics.
Ebolavirus (EBOV) has precipitated sickness outbreaks taking tons of of lives, costing billions of {{dollars}} in administration efforts and threatening good ape populations. EBOV ecology should not be completely understood nonetheless contaminated wildlife and consumption of animal carcasses have been linked to human outbreaks, notably inside the Congo Basin.
Partnering with the Congolese Ministry of Nicely being, we carried out wildlife mortality surveillance and educational outreach inside the northern Republic of Congo (RoC). Designed for EBOV detection and to alert public properly being authorities, we established a low-cost wildlife mortality reporting group masking 50 000 km2.
Concurrently, we delivered educational outreach promoting behavioural change to over 6600 people in rural northern RoC. We achieved specimen assortment by teaching enterprise employees on a protected sampling protocol and equipping geographically distributed bases with sampling kits.
We established in-country diagnostics for EBOV testing, reducing diagnostic turnaround time to a few days and demonstrated the absence of EBOV in 58 carcasses. Central Africa stays a high-risk EBOV space, nonetheless RoC, home to crucial remaining populations of good apes, has not had an epidemic since 2005.
This effort continues to function as an untested early warning system in RoC, the place people and good apes have died from earlier Ebola virus sickness outbreaks. This textual content is part of the theme topic ‘Dynamic and integrative approaches to understanding pathogen spillover’.
sebov-detection
PSMB8 antibody |
|||
| 70R-19589 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal PSMB8 antibody |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA116429 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:2000, WB:1:200-1:1000, IHC:1:25-1:100 |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA018886LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
PSMB8 Antibody |
|||
| 1-CSB-PA775839 | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
|||
PSMB8 Conjugated Antibody |
|||
| C43134 | SAB | 100ul | EUR 476.4 |
PSMB8 Polyclonal Antibody |
|||
| A73468 | EpiGentek |
|
|
PSMB8 Antibody, HRP conjugated |
|||
| 1-CSB-PA018886LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, FITC conjugated |
|||
| 1-CSB-PA018886LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
PSMB8 Antibody, Biotin conjugated |
|||
| 1-CSB-PA018886LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against PSMB8. Recognizes PSMB8 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
Monoclonal PSMB8 Antibody, Clone: 1A5 |
|||
| AMM02864G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PSMB8. The antibodies are raised in Mouse and are from clone 1A5. This antibody is applicable in WB and IHC, ICC, E |
|||
Psmb8/ Rat Psmb8 ELISA Kit |
|||
| ELI-15652r | Lifescience Market | 96 Tests | EUR 1063.2 |
Proteasome subunit beta type-8 (PSMB8) Antibody |
|||
| 20-abx211178 | Abbexa |
|
|
Proteasome subunit beta type-8 (PSMB8) Antibody |
|||
| 20-abx211851 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| 20-abx141396 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| 20-abx114776 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| abx028154-400ul | Abbexa | 400 ul | EUR 627.6 |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| abx028154-80l | Abbexa | 80 µl | EUR 343.2 |
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| 20-abx006453 | Abbexa |
|
|
Proteasome Subunit Beta Type-8 (PSMB8) Antibody |
|||
| abx011689-100ul | Abbexa | 100 ul | EUR 493.2 |
Monoclonal PSMB8 Antibody (monoclonal) (M01), Clone: 1B3 |
|||
| AMM03954G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PSMB8 (monoclonal) (M01). The antibodies are raised in Mouse and are from clone 1B3. This antibody is applicable in WB, IHC and IF, IP, E |
|||
PSMB8 siRNA |
|||
| 20-abx930156 | Abbexa |
|
|
PSMB8 siRNA |
|||
| 20-abx930157 | Abbexa |
|
|
PSMB8 siRNA |
|||
| 20-abx904317 | Abbexa |
|
|
PSMB8 Rabbit pAb |
|||
| A7340-100ul | Abclonal | 100 ul | EUR 369.6 |
PSMB8 Rabbit pAb |
|||
| A7340-200ul | Abclonal | 200 ul | EUR 550.8 |
PSMB8 Rabbit pAb |
|||
| A7340-20ul | Abclonal | 20 ul | EUR 219.6 |
PSMB8 Rabbit pAb |
|||
| A7340-50ul | Abclonal | 50 ul | EUR 267.6 |
PSMB8 Blocking Peptide |
|||
| BF0434-BP | Affbiotech | 1mg | EUR 234 |
PSMB8 protein (His tag) |
|||
| 80R-2608 | Fitzgerald | 100 ug | EUR 386.4 |
|
Description: Purified recombinant PSMB8 protein |
|||
Canine PSMB8 ELISA KIT |
|||
| ELI-15651d | Lifescience Market | 96 Tests | EUR 1113.6 |
Rat PSMB8 shRNA Plasmid |
|||
| 20-abx984734 | Abbexa |
|
|
Human PSMB8 shRNA Plasmid |
|||
| 20-abx953843 | Abbexa |
|
|
Mouse PSMB8 shRNA Plasmid |
|||
| 20-abx971337 | Abbexa |
|
|
PSMB8 Recombinant Protein (Rat) |
|||
| RP222629 | ABM | 100 ug | Ask for price |
PSMB8 Recombinant Protein (Mouse) |
|||
| RP165287 | ABM | 100 ug | Ask for price |
PSMB8 Recombinant Protein (Human) |
|||
| RP085356 | ABM | 100 ug | Ask for price |
Psmb8 ORF Vector (Rat) (pORF) |
|||
| ORF074211 | ABM | 1.0 ug DNA | EUR 607.2 |
PSMB8 ORF Vector (Human) (pORF) |
|||
| ORF028453 | ABM | 1.0 ug DNA | EUR 486 |
Psmb8 ORF Vector (Mouse) (pORF) |
|||
| ORF055097 | ABM | 1.0 ug DNA | EUR 607.2 |
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-100ul | Abclonal | 100 ul | EUR 492 |
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-200ul | Abclonal | 200 ul | EUR 685.2 |
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-20ul | Abclonal | 20 ul | EUR 265.2 |
[KO Validated] PSMB8 Rabbit pAb |
|||
| A19933-50ul | Abclonal | 50 ul | EUR 344.4 |
PSMB8 ELISA Kit (Dog) (OKEH03975) |
|||
| OKEH03975 | Aviva Systems Biology | 96 Wells | EUR 1012.8 |
|
Description: Description of target: ;Species reactivity: Dog;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.064 ng/mL |
|||
PSMB8 ELISA Kit (Human) (OKEH07770) |
|||
| OKEH07770 | Aviva Systems Biology | 96 Wells | EUR 1310.4 |
|
Description: Description of target: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. This gene is located in the class II region of the MHC (major histocompatibility complex). Expression of this gene is induced by gamma interferon and this gene product replaces catalytic subunit 3 (proteasome beta 5 subunit) in the immunoproteasome. Proteolytic processing is required to generate a mature subunit. Two alternative transcripts encoding two isoforms have been identified; both isoforms are processed to yield the same mature subunit.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.06ng/mL |
|||
PSMB8 ELISA Kit (Human) (OKCD02695) |
|||
| OKCD02695 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
|
Description: Description of target: The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH. The proteasome has an ATP-dependent proteolytic activity. This subunit is involved in antigen processing to generate class I binding peptides. Replacement of PSMB5 by PSMB8 increases the capacity of the immunoproteasome to cleave model peptides after hydrophobic and basic residues. Acts as a major component of interferon gamma-induced sensitivity. Plays a key role in apoptosis via the degradation of the apoptotic inhibitor MCL1. May be involved in the inflammatory response pathway. In cancer cells, substitution of isoform 1 (E2) by isoform 2 (E1) results in immunoproteasome deficiency. Required for the differentiation of preadipocytes into adipocytes.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.117 ng/mL |
|||
Psmb8 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6921501 | ABM | 3 x 1.0 ug | EUR 406.8 |
PSMB8 sgRNA CRISPR Lentivector set (Human) |
|||
| K1740301 | ABM | 3 x 1.0 ug | EUR 406.8 |
Psmb8 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4425601 | ABM | 3 x 1.0 ug | EUR 406.8 |
Psmb8 3'UTR GFP Stable Cell Line |
|||
| TU167173 | ABM | 1.0 ml | Ask for price |
PSMB8 3'UTR GFP Stable Cell Line |
|||
| TU069046 | ABM | 1.0 ml | EUR 1672.8 |
Psmb8 3'UTR GFP Stable Cell Line |
|||
| TU266964 | ABM | 1.0 ml | Ask for price |
PSMB8 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV296844 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Rat) (pPB-C-His) |
|||
| PV296842 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Rat) (pPB-N-His) |
|||
| PV296843 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Rat) (pPM-C-His) |
|||
| PV296845 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Human) (pPM-C-HA) |
|||
| PV113812 | ABM | 500 ng | EUR 662.4 |
PSMB8 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV220388 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Human) (pPB-C-His) |
|||
| PV113810 | ABM | 500 ng | EUR 662.4 |
PSMB8 Protein Vector (Human) (pPB-N-His) |
|||
| PV113811 | ABM | 500 ng | EUR 662.4 |
PSMB8 Protein Vector (Human) (pPM-C-His) |
|||
| PV113813 | ABM | 500 ng | EUR 662.4 |
PSMB8 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV220386 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV220387 | ABM | 500 ng | EUR 723.6 |
PSMB8 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV220389 | ABM | 500 ng | EUR 723.6 |
Psmb8 3'UTR Luciferase Stable Cell Line |
|||
| TU117173 | ABM | 1.0 ml | Ask for price |
PSMB8 3'UTR Luciferase Stable Cell Line |
|||
| TU019046 | ABM | 1.0 ml | EUR 1672.8 |
A novel carbon nanoparticle probe-based ultrasensitive lateral circulation assay for quick detection of Ebola virus.
Ebola virus (EBOV) is an terribly contagious pathogen first present in Africa associated to excessive hemorrhagic sickness in individuals and nonhuman primates, which has resulted in at least 28 500 suspected circumstances and 11 300 confirmed deaths in 2014-2016 Ebola epidemic in West Africa.
Speedy and delicate detection of EBOV is the essential factor to rising the likelihood of survival and reducing an an infection costs in pandemic areas. Proper right here, we report an ultrasensitive and instrument-free EBOV detection assay primarily based totally on colloidal carbon immunochromatography.
Carbon nanoparticle-labeled rabbit anti-EBOV-VP40 IgG had been concentrated inside the conjugate pad, monoclonal antibody (McAb, 4B7F9) in the direction of EBOV-VP40 and goat anti-rabbit IgG had been immobilized on the nitrocellulose membrane with 2 μL/cm at a spotlight of 1 mg/mL as check out and administration strains, respectively.
Then the sample software program pad, conjugate launch pad, nitrocellulose membrane and absorbent pad had been assembled proper right into a lateral circulation check out strip.
The check out strip reveals strong specificity in the direction of related viruses that share comparable medical indicators and geographic fluctuate with EBOV, along with marburg virus, influenza virus, yellow fever virus and dengue virus. In addition to, 1 500 damaging serums had been examined with false-positive value of 1.3‰ which significantly lower than that of ReEBOV™ colloidal gold check out bundle helpful by World Nicely being Group (WHO).
The sensitivity of this strip was analyzed using inactivated EBOV with detection prohibit of 100 ng/mL (10⁶ copies/mL) which clearly elevated than that of ReEBOV™ dipstick (10⁸ copies/mL). Furthermore, the strip confirmed wonderful thermal stability traits in room temperature and is likely to be as a point-of-care (POC), ultra-sensitive and specific promising candidate for EBOV serological screening in rural Africa or entry/exit ports.
A Survey of Virus Recombination Uncovers Canonical Choices of Artificial Chimeras Generated All through Deep Sequencing Library Preparation.
Chimeric reads could also be generated by in vitro recombination all through the preparation of high-throughput sequencing libraries.
Our attempt to detect natural recombination between the genomes of dengue virus (DENV; +ssRNA genome) and its mosquito host using the Illumina Nextera sequencing library preparation bundle revealed that almost all, if not all, detected host-virus chimeras had been artificial.
Definitely, these chimeras weren’t further frequent than with administration RNA from one different species (a pillbug), which was certainly not in contact with DENV RNA earlier to the library preparation.
The proportion of chimera varieties merely mirrored these of the three species amongst sequencing reads. Chimeras had been repeatedly characterised by the presence of 1-20 bp microhomology between recombining fragments.
Inside-species chimeras principally involved fragments in reverse orientations and located decrease than 100 bp from each other inside the parental genome.
We found comparable choices in printed datasets using two totally different viruses: Ebola virus (EBOV; -ssRNA genome) and a herpesvirus (dsDNA genome), every produced with the Illumina Nextera protocol. These canonical choices counsel that artificial chimeras are generated by intra-molecular template switching of the DNA polymerase all through the PCR step of the Nextera protocol.
Lastly, a broadcast Illumina dataset using the Flock Residence virus (FHV; +ssRNA genome) generated with a protocol stopping artificial recombination revealed the presence of 1-10 bp microhomology motifs in FHV-FHV chimeras, nonetheless just a few recombining fragments had been in reverse orientations.
Our analysis uncovered sequence choices characterizing recombination breakpoints in short-read sequencing datasets, which can be helpful to guage the presence and extent of artificial recombination.
Influenza A Virus H3N2 Brisbane 10 / 07 Protein |
|||
| 20-abx260509 | Abbexa |
|
|
Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen |
|||
| 11-567 | ProSci | 0.1 mg | EUR 632.4 |
|
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2) |
|||
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
| 11-563 | ProSci | 0.05 mg | EUR 632.4 |
|
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
| 11-564 | ProSci | 0.05 mg | EUR 632.4 |
|
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide |
|||
Influenza A H1N1pdm (Brisbane/2/18) Culture Fluid (Heat Inactivated) (1 mL) |
|||
| 0810585CFHI | Zeptometrix | 1 mL | EUR 422 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-10ug |
|||
| QP12081-10ug | EnQuireBio | 10ug | EUR 186 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-1mg |
|||
| QP12081-1mg | EnQuireBio | 1mg | EUR 2470.8 |
Recombinant Influenza H3N2 Brisbane Protein, Untagged, Insect-50ug |
|||
| QP12081-50ug | EnQuireBio | 50ug | EUR 241.2 |
Recombinant (HEK) purified Influenza A nucleoprotein (H1N1-NP/1-486aa) protein (A/Brisbane/59/2007, >95%, His-tag) |
|||
| H1NP26-R-25 | Alpha Diagnostics | 25 ug | EUR 416.4 |
Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag) |
|||
| HA1B012-R-10 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant (HEK) purified Influenza B HA1 protein (B/Brisbane/60/2008)(aa.16-363, >95%, his-tag) |
|||
| HA1B012-R-100 | Alpha Diagnostics | 100 ug | EUR 927.6 |
Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag) |
|||
| HA1B013-R-10 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant (HEK) purified Influenza B HA protein (B/Brisbane/60/2008, ?TM, 16-548aa, >95%, his-tag) |
|||
| HA1B013-R-100 | Alpha Diagnostics | 100 ug | EUR 927.6 |
IAV H3N2 nucleoprotein (A/Brisbane/10/2007) [His] |
|||
| DAG2329 | Creative Diagnostics | 100 µg | EUR 868.8 |
IAV H3N2 (aa 18-530) (A/Brisbane/10/2007) [His] |
|||
| DAG1693 | Creative Diagnostics | 50 ug | EUR 2017.2 |
IAV H3N2 non-structural 1 (A/Brisbane/10/2007 ) [His] |
|||
| DAG2335 | Creative Diagnostics | 100 µg | EUR 868.8 |
IAV H3N2 Hemagglutinin (aa 17-530) (A/Brisbane/10/2007) [His] |
|||
| DAG2224 | Creative Diagnostics | 100 µg | EUR 1095.6 |
IAV H1N1 nucleoprotein (aa 1-486) (A/Brisbane/10/2007) [His] |
|||
| DAG2328 | Creative Diagnostics | 100 µg | EUR 868.8 |
Mouse Monoclonal Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG |
|||
| H3N21-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-Influenza A HA (H3N2, 1-531aa/HA1+HA2) (A/Brisbane/10/2007) protein IgG, aff pure |
|||
| H3N23-A | Alpha Diagnostics | 100 ul | EUR 534 |
IAV H3N2 Hemagglutinin 1 (aa 17-345) (A/Brisbane/10/2007) [His] |
|||
| DAG2282 | Creative Diagnostics | 100 µg | EUR 1095.6 |
IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His] |
|||
| DAG1688 | Creative Diagnostics | 50 ug | EUR 2017.2 |
Influenza A H3 Antibody |
|||
| abx021977-1mg | Abbexa | 1 mg | EUR 1053.6 |
Influenza A H3 Antibody |
|||
| abx021978-1mg | Abbexa | 1 mg | EUR 1053.6 |
IAV H1N1 Hemagglutin (aa 51-301) (A/Brisbane/59/2007) [His] |
|||
| DAG2202 | Creative Diagnostics | 100 µg | EUR 1095.6 |
IAV H1N1 Hemagglutin (aa 18-530) (A/Brisbane/59/2007) [His] |
|||
| DAG2220 | Creative Diagnostics | 100 µg | EUR 1095.6 |
Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007) |
|||
| VAng-Wyb7007-100g | Creative Biolabs | 100 µg | EUR 2089.2 |
|
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein. |
|||
Recombinant IAV H3N2 Hemagglutinin / HA Protein (aa 1-530) [His] (A/Brisbane/10/2007) |
|||
| VAng-Wyb7007-50g | Creative Biolabs | 50 µg | EUR 1260 |
|
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin / HA, recombinant protein. |
|||
IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His] |
|||
| DAG1775 | Creative Diagnostics | 50 ug | EUR 2017.2 |
IAV H1N1 Hemagglutin 1 (aa 18-343) (A/Brisbane/59/2007) [His] |
|||
| DAG2279 | Creative Diagnostics | 100 µg | EUR 1095.6 |
IAV H3N2 Hemagglutinin 1 (aa 17-346) (A/Brisbane/299/2011 ) [His] |
|||
| DAG2246 | Creative Diagnostics | 100 µg | EUR 1095.6 |
Recombinant IAV H1N1 Protein (aa 18-530) (A/Brisbane/59/2007) [His] |
|||
| VAng-Lsx0333-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: IAV H1N1 (aa 18-530) (A/Brisbane/59/2007) [His], recombinant protein from HEK 293 cells. |
|||
Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007) |
|||
| VAng-Wyb7063-100g | Creative Biolabs | 100 µg | EUR 2089.2 |
|
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein. |
|||
Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007) |
|||
| VAng-Wyb7063-10g | Creative Biolabs | 10 µg | EUR 687.6 |
|
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein. |
|||
Recombinant IAV H3N2 Hemagglutinin HA1 Subunit Protein (aa 1-345) [His] (A/Brisbane/10/2007) |
|||
| VAng-Wyb7063-50g | Creative Biolabs | 50 µg | EUR 1260 |
|
Description: Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin HA1 Subunit, recombinant protein. |
|||
Influenza A virus H3 PCR kit |
|||
| PCR-H649-48R | Bioingentech | 50T | EUR 987.6 |
Influenza A virus H3 PCR kit |
|||
| PCR-H649-96R | Bioingentech | 100T | EUR 1335.6 |
Influenza A Virus H3 Antigen Antibody |
|||
| abx415738-01mg | Abbexa | 0.1 mg | EUR 861.6 |
Influenza A virus H3 RT PCR kit |
|||
| RTq-H649-100R | Bioingentech | 100T | EUR 1573.2 |
Influenza A virus H3 RT PCR kit |
|||
| RTq-H649-150R | Bioingentech | 150T | EUR 2144.4 |
Influenza A virus H3 RT PCR kit |
|||
| RTq-H649-50R | Bioingentech | 50T | EUR 1155.6 |
IBV Hemagglutinin (aa 16-548) (B/Brisbane/60/2008) [His] |
|||
| DAG2215 | Creative Diagnostics | 100 µg | EUR 1095.6 |
IBV Nucleoprotein (aa 1-560) (B/Brisbane/60/2008) [His] |
|||
| DAG2319 | Creative Diagnostics | 100 µg | EUR 868.8 |
Influenza B Virus Florida 07/04 |
|||
| 7-07918 | CHI Scientific | 10µg | Ask for price |
Influenza B Virus Florida 07/04 |
|||
| 7-07919 | CHI Scientific | 50µg | Ask for price |
Influenza B Virus Florida 07/04 |
|||
| 7-07920 | CHI Scientific | 1mg | Ask for price |
IBV Matrix Proteins 1 (aa 1-252) (B/Brisbane/60/2008) [His] |
|||
| DAG2304 | Creative Diagnostics | 100 µg | EUR 868.8 |
IBV Matrix Proteins 1 (aa 1-248) (B/Brisbane/60/2008) [His] |
|||
| DAG2305 | Creative Diagnostics | 100 µg | EUR 868.8 |
Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007) |
|||
| VAng-Wyb6941-100g | Creative Biolabs | 100 µg | EUR 2092.8 |
|
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein. |
|||
Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007) |
|||
| VAng-Wyb6941-10g | Creative Biolabs | 10 µg | EUR 687.6 |
|
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein. |
|||
Recombinant IAV H1N1 Hemagglutinin / HA Protein (aa 1-528) [His] (A/Brisbane/59/2007) |
|||
| VAng-Wyb6941-50g | Creative Biolabs | 50 µg | EUR 1260 |
|
Description: Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin / HA, recombinant protein. |
|||
Influenza A virus H3 One-Step PCR kit |
|||
| Oneq-H649-100R | Bioingentech | 100T | EUR 1932 |
Influenza A virus H3 One-Step PCR kit |
|||
| Oneq-H649-150R | Bioingentech | 150T | EUR 2646 |
Influenza A virus H3 One-Step PCR kit |
|||
| Oneq-H649-50R | Bioingentech | 50T | EUR 1410 |
Influenza B (B / Florida / 07 / 04) Protein |
|||
| abx060630-1mg | Abbexa | 1 mg | EUR 2247.6 |
Influenza B Virus Florida 07 / 04 Protein |
|||
| 20-abx260511 | Abbexa |
|
|
Recombinant IBV Hemagglutinin Protein (aa 16-548) (B/Brisbane/60/2008) [His] |
|||
| VAng-Lsx0372-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: IBV Hemagglutinin (aa 16-548) (B/Brisbane/60/2008) [His], recombinant protein from HEK 293 cells. |
|||
Influenza A protein |
|||
| 30-1303 | Fitzgerald | 1 mg | EUR 289.2 |
|
Description: Purified native Influenza A protein |
|||
Influenza A protein |
|||
| 30-1304 | Fitzgerald | 1 mg | EUR 354 |
|
Description: Purified native Influenza A protein |
|||
Influenza A protein |
|||
| 30-1305 | Fitzgerald | 1 mg | EUR 354 |
|
Description: Purified native Influenza A protein |
|||
Influenza A protein |
|||
| 30-1306 | Fitzgerald | 1 ml | EUR 354 |
|
Description: Purified native Influenza A protein |
|||
Influenza A protein |
|||
| 30-AI50 | Fitzgerald | 1 ml | EUR 314.4 |
|
Description: Purified Influenza A protein (H1N1 strain) |
|||
Influenza A protein |
|||
| 30-AI60 | Fitzgerald | 1 ml | EUR 314.4 |
|
Description: Purified Influenza A protein (H3N2 strain) |
|||
Influenza A protein |
|||
| 30-1002 | Fitzgerald | 100 ug | EUR 418.8 |
|
Description: Recombinant Influenza A protein (NP antigen) |
|||
Influenza A antibody |
|||
| 10-1096 | Fitzgerald | 500 ug | EUR 249.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1097 | Fitzgerald | 1 mg | EUR 418.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1098 | Fitzgerald | 1 mg | EUR 726 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1099 | Fitzgerald | 1 mg | EUR 726 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1100 | Fitzgerald | 500 ug | EUR 418.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1101 | Fitzgerald | 1 mg | EUR 726 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1102 | Fitzgerald | 500 ug | EUR 418.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1103 | Fitzgerald | 500 ug | EUR 418.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1241 | Fitzgerald | 500 ug | EUR 418.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-1243 | Fitzgerald | 500 ug | EUR 418.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-7866 | Fitzgerald | 1 mg | EUR 483.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-7867 | Fitzgerald | 1 mg | EUR 483.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50A | Fitzgerald | 1 mg | EUR 603.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50B | Fitzgerald | 1 mg | EUR 470.4 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50C | Fitzgerald | 1 mg | EUR 470.4 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50D | Fitzgerald | 1 mg | EUR 334.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50E | Fitzgerald | 1 mg | EUR 334.8 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50F | Fitzgerald | 1 mg | EUR 327.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50G | Fitzgerald | 1 mg | EUR 489.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50H | Fitzgerald | 1 mg | EUR 649.2 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50I | Fitzgerald | 1 mg | EUR 489.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50K | Fitzgerald | 1 mg | EUR 327.6 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50L | Fitzgerald | 1 mg | EUR 360 |
|
Description: Mouse monoclonal Influenza A antibody |
|||
Influenza A antibody |
|||
| 10-I50M | Fitzgerald | 1 mg | EUR 360 |
|
Description: Mouse monoclonal Influenza A antibody |
|||